Citations

Mayo Clinic

Showing 10 of 108551 citations.

Eosinophilic esophagitis: Does age matter?
O’Sullivan, Donnchadh , Cárdenas, María C. , Ricaurte, Luisa , Moreira, Roger K. , Weaver, Amy L. , Hopson, Puanani , Absah, Imad , Camila Cardenas, Maria, Moreira, Roger

Journal of Pediatric Gastroenterology and Nutrition | April 2, 2024 | Volume: 78 | Issue: 6 | Pages: 1329-1336

10.1002/jpn3.12201 | PMID 38562024 Get It

AbstractObjectivesEosinophilic esophagitis (EoE) is often diagnosed in school‐age children between 6‐ and 9‐year‐old. There is less known about those who are diagnosed with EoE that are younger than 6 years old. The objective of this study is to compare clinical presentation, comorbidities, and outcomes based on age at diagnosis of EoE.MethodsSingle‐center retrospective chart review of children (<18 years) diagnosed with EoE between 2005 and 2020. We recorded demographics, clinical presentation, family history, past medical history, treatment, and endoscopic findings. Children in this cohort were classified based on age into three age groups: <2 years, 2−<6 years, and 6−<18 years.ResultsWe identified 256 children with EoE, the mean age (SD) at the time of diagnosis was 9 (5.2) years and 184 (72%) were male. We had 164 (64%) patients with available follow‐up esophagogastroduodenoscopies (EGDs) data (495 EGDs in total) of those 99/164 (60%) reached mucosal remission. In the very young children (<2 years) vomiting was the most common presentation, while poor weight gain was seen more in the 2−<6‐year group in comparison to the >6‐years. Food impaction and abdominal pain were most likely to present in older children 6−18 years. Combination therapy, as opposed to a single therapy, induced remission at a higher frequency in the <6‐year group in comparison to the 6−<18‐year group (85% vs. 66%).ConclusionEoE should be considered in younger children presenting with feeding difficulty and poor weight gain. Combination therapy seems to be more effective in younger children with EoE, but further studies with bigger sample size are needed to study the efficacy of the different combination therapies.
Opportunity for a Community Health Fair Model of Bleeding Control Training
DePolo, Nicole, Dellen, Matthew, Ike, Andre, Lum, Sharon S. , Mukherjee, Kaushik , Turay, David, Burruss, Sigrid , Hughes, Elizabeth

The American Surgeon™ | April 2, 2024 | Volume: 90 | Issue: 6 | Pages: 1540-1544

10.1177/00031348241241745 | PMID 38562123 Get It

Background Traumatic hemorrhage is a prevalent cause of death nationally, with >50% of civilian deaths estimated to be preventable with more timely intervention. This study investigated the efficacy of training large and diverse audiences in bleeding control methods including tourniquets in community health fair settings. Methods A booth was utilized for bleeding control training at community health fairs via direct demonstrations of pressure, wound packing, and commercial and improvised tourniquet application followed by hands-on practice. Participants self-rated their perceived abilities while instructors rated the participant competency. Results 117 community members participated during two fairs, though not every person completed every portion of the training. Average age was 33 (range 6-82) and the majority were female (65.0%). There was no difference in self-perceived skill compared to trainer grading of participant’s ability to identify life-threatening bleeding (112 (97.4%) vs 106 (97.2%); P = 1), apply pressure (113 (98.3%) vs 106 (97.2%); P = .68), and pack a wound (102 (88.7%) vs 92 (84.4%); P = .43). No difference in difficulty was noted in placing commercial vs improvised tourniquets (16 (43%) vs 14 (45%); P = .87). However, participants were overconfident in their ability to place tourniquets compared to trainer grading, respectively (112 (98.2%) vs 100 (91.7%; P = .03)). Discussion Community fair classes provide opportunities to train large and diverse audiences in bleeding control techniques. However, participants overestimated their ability to appropriately apply tourniquets. Further investigation is needed into best educational approaches to optimize the impact of bleeding control kits that have been distributed in multiple states.
Plexiform neurofibroma masquerading as a giant congenital melanocytic nevus
Olsen, Gerilyn M. , Siegel, Dawn H. , Sokumbi, Olayemi , Chiu, Yvonne E , Sokumbi, Olayemi , Chiu, Yvonne E.

Pediatric Dermatology | April 2, 2024 | Volume: 41 | Issue: 5 | Pages: 878-880

10.1111/pde.15611 | PMID 38561464 Get It

AbstractA 4‐month‐old male presented for a large, hypertrichotic brown patch on the upper back with several scattered 0.5–1.5 cm, round to oval, brown macules and patches on the trunk and extremities. The lesion was initially diagnosed as a giant congenital melanocytic nevus based on clinical exam and histopathology with immunohistochemical stains. The patient was later diagnosed with neurofibromatosis type 1, and the lesion on the back developed a “bag of worms” texture consistent with a plexiform neurofibroma and found to harbor a pathogenic variant in the NF1 gene. This case highlights the diagnostic challenge of differentiating these lesions and their overlapping clinical and histopathological features.
Anticoagulation Patterns Among Community-Dwelling Older Adults With Atrial Fibrillation
Costello, Meaghan, Tung, Ericka E. , Jaeger, Thomas M. , Fischer, Karen M.

Journal of Primary Care & Community Health | April 2, 2024 | Volume: 15 | Issue: No issue available | Pages: No page available

10.1177/21501319241243005 | PMID 38561977 Get It

Objectives: To assess clinicians’ prescribing practices for anticoagulation in older adults with atrial fibrillation or atrial flutter (AF/F) and determine factors common among those without anticoagulation. Methods: We performed a community-based retrospective cohort study of adults aged 65 years and older with a history of nonvalvular AF/F to determine the rate of oral anticoagulation utilization. We also assessed for associations between anticoagulation use and comorbid conditions and common geriatric syndromes. Results: A total of 3832 patients with a diagnosis of nonvalvular AF/F were included (mean [SD] age, 79.9 [8.4] years), 2693 (70.3%) of whom were receiving anticoagulation (51.7%, a vitamin K antagonist; 48.1%, a direct-acting oral anticoagulant). Patients with higher Elderly Risk Assessment index (ERA) scores, a surrogate for health vulnerability, received anticoagulation less often than patients with lower scores. The percentage of patients with a history of falling was higher among those who did not receive anticoagulation than among those who did (44.4% vs 32.8%; P < .001). Similarly, a diagnosis of dementia was more common in the no-anticoagulation group than the anticoagulation group (18.5% vs 12.7%; P < .001). Conclusions: A substantial proportion of older adults with AF/F do not receive anticoagulation. Those without anticoagulation had higher risk of health deterioration based on higher ERA scores and had a higher incidence of dementia and fall history. This suggests that the presence of geriatric syndromes may influence the decision to withhold anticoagulation.
A call for universal definition of myocardial infarction after cardiac surgery
Thygesen, Kristian , Jaffe, Allan S. , Jaffe, Allan S.

European Journal of Cardio-Thoracic Surgery | April 2, 2024 | Volume: 65 | Issue: 4 | Pages: No page available

10.1093/ejcts/ezae130 | PMID 38561174 Get It

Case Presentation of Autoimmune Septin‐5 Cerebellar Ataxia
Nijim, Wasef , Morgan, John C. , Montalvo, Mayra , McKeon, Andrew, McLeod, Colin , McKeon, Andrew , McLeod, Colin

Movement Disorders Clinical Practice | April 2, 2024 | Volume: 11 | Issue: 6 | Pages: 734-737

10.1002/mdc3.14028 | PMID 38561872 Get It

Trends in Colorectal Cancer Screening from the National Health Interview Survey: Analysis of the Impact of Different Modalities on Overall Screening Rates
Ebner, Derek W. , Rutten, Lila J. Finney , Miller‐Wilson, Lesley‐Ann , Markwat, Niels , Vahdat, Vahab , Ozbay, A. Burak , Limburg, Paul J. , Finney Rutten, Lila J , Ozbay, A Burak , Limburg, Paul J , Vahdat, Vahab , Ebner, Derek

Cancer Prevention Research | April 2, 2024 | Volume: 17 | Issue: 6 | Pages: 275-280

10.1158/1940-6207.capr-23-0443 | PMID 38561018 Get It

Abstract Colorectal cancer is the second leading cause of cancer-related mortality in adults in the United States. Despite compelling evidence of improved outcomes in colorectal cancer, screening rates are not optimal. This study aimed to characterize colorectal cancer screening trends over the last two decades and assess the impact of various screening modalities on overall colorectal cancer screening rates. Using National Health Interview Survey data from 2005 to 2021, we examined colorectal cancer screening [colonoscopy, multitarget stool DNA (mt-sDNA), fecal occult blood test (FOBT)/fecal immunochemical test, sigmoidoscopy, CT colonography] rates among adults ages 50–75 years (n = 85,571). A pseudo-time-series cross-sectional (pseudo-TSCS) analysis was conducted including a random effects generalized least squares regression model to estimate the relative impact of each modality on changes in colorectal cancer screening rates. Among 50 to 75 year olds, the estimated colorectal cancer screening rate increased from 47.7% in 2005 to 69.9% in 2021, with the largest increase between 2005 and 2010 (47.7%–60.7%). Rates subsequently plateaued until 2015 but increased from 63.5% in 2015 to 69.9% in 2018. This was primarily driven by the increased use of mt-sDNA (2.5% in 2018 to 6.6% in 2021). Pseudo-TSCS analysis results showed that mt-sDNA contributed substantially to the increase in overall screening rates (77.3%; P &lt; 0.0001) between 2018 and 2021. While colorectal cancer screening rates increased from 2005 to 2021, they remain below the 80% goal. The introduction of mt-sDNA, a noninvasive screening test may have improved overall rates. Sustained efforts are required to further increase screening rates to improve patient outcomes and offering a range of screening options is likely to contribute to achieving this goal. Prevention Relevance: This retrospective study highlights the importance of convenient stool-based colorectal cancer screening options to achieve the national goal of 80% for overall colorectal cancer screening rates. Empowering screening-eligible individuals with a choice for their colorectal cancer screening tests is imperative.
Improving Outcome in Severe Myasthenia Gravis and Guillain–Barré Syndrome
Hawkes, Maximiliano A. , Wijdicks, Eelco F. M.

Seminars in Neurology | April 1, 2024 | Volume: 44 | Issue: 03 | Pages: 263-270

10.1055/s-0044-1785509 | PMID 38560985 Get It

AbstractWhen progressive and severe, myasthenia gravis and Guillain–Barré syndrome may have the potential for fatal and unfavorable clinical outcomes. Regardless of important differences in their clinical course, the development of weakness of oropharyngeal muscles and respiratory failure with requirement of mechanical ventilation is the main driver of poor prognosis in both conditions. The need for prolonged mechanical ventilation is particularly relevant because it immobilizes the patient and care becomes extraordinarily complex due to daily risks of systemic complications. Additionally, patients with myasthenia gravis often require long-term immunosuppressive treatments with associated toxicity and infectious risks. Unlike myasthenia gravis, the recovery period is prolonged in Guillain–Barré syndrome, but often favorable, even in the more severely affected patients. Outcome, for a large part, is determined by expert neurocritical care.
In T2DM, periconceptional, noninsulin, second-line antidiabetes medications were not linked to major congenital malformations vs. insulin
Egan, Aoife M.

Annals of Internal Medicine | April 1, 2024 | Volume: 177 | Issue: 4 | Pages: JC47

10.7326/j24-0015 | PMID 38560907 Get It

Sudden Cardiac Death or Ventricular Arrythmia in Patients Taking Levetiracetam or Oxcarbazepine
Cross, Madeline R., Sangaralingham, Lindsey R. , So, Elson L., Ackerman, Michael J. , Noseworthy, Peter A. , Savitz, Samuel T. , Noseworthy, Peter A

Neurology | April 1, 2024 | Volume: 102 | Issue: 9 | Pages: No page available

10.1212/wnl.0000000000209177 | PMID 38560823 Get It